Brian Park, PharmD

Drug Information Specialist https://www.renalandurologynews.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Acute Kidney Injury

Therapeutic Peptide Granted Orphan Drug Status for Hepatorenal Syndrome

Brian Park, PharmD

September 21, 2022

The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury.

End-Stage Renal Disease

Novel Anticoagulant Therapy for Patients With ESRD Gets Fast Track Status

Brian Park, PharmD

August 31, 2022

MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.

Prostate Cancer

Olaparib + Abiraterone Gets Priority Review for Castration-Resistant Prostate Cancer

Brian Park, PharmD

August 22, 2022

The sNDA is supported by data from the phase 3 PROpel trial which included adults with mCRPC in the first-line setting.

Cardiovascular Disease (CVD)

FDA Clears Bodyport Cardiac Scale to Monitor Heart Function, Fluid Status

Brian Park, PharmD

August 19, 2022

The Bodyport Cardiac Scale is designed to detect signals through an individual’s feet to noninvasively measure a broad spectrum of hemodynamic biomarkers for heart function and fluid status.